135 related articles for article (PubMed ID: 14597408)
1. Early stage-specific inhibitions of cardiomyocyte differentiation and expression of Csx/Nkx-2.5 and GATA-4 by phosphatidylinositol 3-kinase inhibitor LY294002.
Naito AT; Tominaga A; Oyamada M; Oyamada Y; Shiraishi I; Monzen K; Komuro I; Takamatsu T
Exp Cell Res; 2003 Nov; 291(1):56-69. PubMed ID: 14597408
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
3. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.
Wilson EM; Tureckova J; Rotwein P
Mol Biol Cell; 2004 Feb; 15(2):497-505. PubMed ID: 14595115
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.
Chandrasekar B; Mummidi S; Claycomb WC; Mestril R; Nemer M
J Biol Chem; 2005 Feb; 280(6):4553-67. PubMed ID: 15574430
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4.
Monzen K; Shiojima I; Hiroi Y; Kudoh S; Oka T; Takimoto E; Hayashi D; Hosoda T; Habara-Ohkubo A; Nakaoka T; Fujita T; Yazaki Y; Komuro I
Mol Cell Biol; 1999 Oct; 19(10):7096-105. PubMed ID: 10490646
[TBL] [Abstract][Full Text] [Related]
6. Myogenic signaling by lithium in cardiomyoblasts is Akt independent but requires activation of the beta-catenin-Tcf/Lef pathway.
Kashour T; Burton T; Dibrov A; Amara F
J Mol Cell Cardiol; 2003 Aug; 35(8):937-51. PubMed ID: 12878481
[TBL] [Abstract][Full Text] [Related]
7. The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells.
Kamei T; Jones SR; Chapman BM; MCGonigle KL; Dai G; Soares MJ
Mol Endocrinol; 2002 Jul; 16(7):1469-81. PubMed ID: 12089343
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor (HGF) enhances cardiac commitment of differentiating embryonic stem cells by activating PI3 kinase.
Roggia C; Ukena C; Böhm M; Kilter H
Exp Cell Res; 2007 Mar; 313(5):921-30. PubMed ID: 17258200
[TBL] [Abstract][Full Text] [Related]
9. Expression of human TFF3 in relation to growth of HT-29 cell subpopulations: involvement of PI3-K but not STAT6.
Durual S; Blanchard C; Estienne M; Jacquier MF; Cuber JC; Perrot V; Laboisse C; Cuber JC
Differentiation; 2005 Feb; 73(1):36-44. PubMed ID: 15733066
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
[TBL] [Abstract][Full Text] [Related]
11. L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway.
Sarker KP; Lee KY
Oncogene; 2004 Aug; 23(36):6064-70. PubMed ID: 15208659
[TBL] [Abstract][Full Text] [Related]
12. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
[TBL] [Abstract][Full Text] [Related]
13. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B.
Jiang BH; Aoki M; Zheng JZ; Li J; Vogt PK
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2077-81. PubMed ID: 10051597
[TBL] [Abstract][Full Text] [Related]
14. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad.
Shimamura H; Terada Y; Okado T; Tanaka H; Inoshita S; Sasaki S
J Am Soc Nephrol; 2003 Jun; 14(6):1427-34. PubMed ID: 12761242
[TBL] [Abstract][Full Text] [Related]
15. PI3-kinase regulates survival of chronic lymphocytic leukemia B-cells by preventing caspase 8 activation.
Plate JM
Leuk Lymphoma; 2004 Aug; 45(8):1519-29. PubMed ID: 15370202
[TBL] [Abstract][Full Text] [Related]
16. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling.
Patten RD; Pourati I; Aronovitz MJ; Baur J; Celestin F; Chen X; Michael A; Haq S; Nuedling S; Grohe C; Force T; Mendelsohn ME; Karas RH
Circ Res; 2004 Oct; 95(7):692-9. PubMed ID: 15345655
[TBL] [Abstract][Full Text] [Related]
17. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.
Nakamura JL; Karlsson A; Arvold ND; Gottschalk AR; Pieper RO; Stokoe D; Haas-Kogan DA
J Neurooncol; 2005 Feb; 71(3):215-22. PubMed ID: 15735908
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase regulates differentiation of H9c2 cardiomyoblasts mainly through the protein kinase B/Akt-independent pathway.
Kim JM; Yoon MY; Kim J; Kim SS; Kang I; Ha J; Kim SS
Arch Biochem Biophys; 1999 Jul; 367(1):67-73. PubMed ID: 10375400
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity.
Zhang L; Himi T; Morita I; Murota S
Cell Death Differ; 2001 May; 8(5):528-36. PubMed ID: 11423913
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
Uddin S; Kottegoda S; Stigger D; Platanias LC; Wickrema A
Biochem Biophys Res Commun; 2000 Aug; 275(1):16-9. PubMed ID: 10944433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
